- Home>
- Journal Watch
- >
- cutaneous T-cell lymphoma
Search for cutaneous T-cell lymphoma in all Journal Watch editions
Physician-authored summaries on the latest research on cutaneous T-cell lymphoma, editorials on cutaneous T-cell lymphoma, and perspectives on cutaneous T-cell lymphoma - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 57 results - Relevance
- Date
You searched for: cutaneous T-cell lymphoma
-
Gene Forecasters: Prognostic Markers for CTCL
- May 7, 2010
- Craig A. Elmets, MD
- Dermatology
Genetic analysis can indicate risk for progression and outcomes in patients with cutaneous T-cell lymphoma.- Reviewing:
- Litvinov IV et al., Clin Cancer Res 2010 Apr 1; 16:2106.
-
Not Only B but Also T: Lymphomas Localized to the Leg
- September 11, 2009
- Angelica Maria Selim, MD
- Dermatology
In a new variant of cutaneous T-cell lymphoma, tumor aggression is again associated with location.- Reviewing:
- Poligone B et al., Arch Dermatol 2009 Jun; 145:677.
-
Vorinostat for T-Cell Lymphoma
- February 5, 2007
- Michael E. Williams, MD
- Oncology and Hematology
The novel oral agent vorinostat exhibits therapeutic activity in patients with relapsed and refractory cutaneous T-cell lymphoma.- Reviewing:
- Duvic M et al., Blood 2007 Jan 1; 109:31-9.
-
Mycosis Fungoides: Is a Double Negative a Plus?
- September 22, 2006
- Angelica Selim, MD
- Dermatology
An atypical clinical presentation is more likely in this rare variant of early-stage MF.- Reviewing:
- Hodak E et al., J Am Acad Dermatol 2006 Aug; 55:276-84.
-
In Search of Prognostic Markers in Mycosis Fungoides
- October 25, 2005
- Angelica Selim, MD
- Dermatology
Mycosis fungoides (MF), the most common cutaneous T-cell lymphoma (CTCL), varies widely in symptoms and outcome. The disease may be stable and limited to the . . .- Reviewing:
- Juarez T et al., Arch Dermatol 2005 Sep; 141:1107-13. Guitart J., Arch Dermatol 2005 Sep; 141:1159-60.
-
Cutaneous T-Cell Lymphoma and Defective Apoptosis: Fas Pathway
- December 14, 2012
- Angelica Selim, MD
- Dermatology
Some CTCL phenotypes were associated with resistance to apoptosis.- Reviewing:
- Stutz N et al., J Am Acad Dermatol 2012 Dec; 67:1327.e1.
-
Granulomatous Processes and Clonality: PCR Evaluation of T-Cell Rearrangement for Diagnosis
- January 6, 2012
- Angelica Selim, MD
- Dermatology
Analysis of T-cell clonality is useful for differentiating sarcoidosis and primary granuloma annulare from granulomatous CTCLs.- Reviewing:
- Pfaltz K et al., Am J Dermatopathol 2011 Oct; 33:659.
-
Mycosis Fungoides with Granulomas: One Story, Two Endings
- February 6, 2009
- Angelica Selim, MD
- Dermatology
The granulomatous mycosis fungoides subtype requires aggressive care and surveillance.- Reviewing:
- Kempf W et al., Arch Dermatol 2008 Dec; 144:1609.
-
A New WHO-EORTC System for Classifying Primary Cutaneous B-Cell Lymphomas Free
- May 4, 2007
- Angelica Selim, MD
- Dermatology
Reclassification using a new system yielded some changes in diagnosis.- Reviewing:
- Senff NJ et al., J Clin Oncol 2007 Apr 20; 25:1581-7.
-
Health Implications of Psoriasis: More Than Just Skin Deep Free
- October 27, 2006
- Craig A. Elmets, MD
- Dermatology
The inflammatory process might be involved in the association between psoriasis and myocardial infarction.- Reviewing:
- Gelfand JM et al., JAMA 2006 Oct 11; 296:1735-41. Gelfand JM et al., J Invest Dermatol 2006 Oct; 126:2194-201.
-
Predicting Prognosis in CTCL
- July 26, 2005
- Neil H. Shear, MD, FRCPC
- Dermatology
The CTCL Severity Index is a useful tool for individualized prognosis in cutaneous T-cell lymphoma.- Reviewing:
- Klemke CD et al., Br J Dermatol 2005 Jul; 153:118-24.
-
A Black-Box Warning for Tacrolimus and Pimecrolimus
- May 6, 2005
- Robert Sidbury, MD
- Pediatrics and Adolescent Medicine
Recently, the FDA mandated a “black-box” warning label for the topical nonsteroidal anti-inflammatory agents tacrolimus and pimecrolimus. The reasons for that decision, and the implications . . . -
A Newly Described, Rare Variant of Cutaneous T-Cell Lymphoma
- September 11, 2000
- BR Smoller
- Dermatology
The vast majority of cutaneous T-cell lymphomas are CD4+ lymphomas with clonal rearrangements of the αβ T-cell receptor. This reflects the fact that 95 percent . . .- Reviewing:
- Toro JR et al., Arch Dermatol 2000 Aug; 136:
1024 1032 .
-
An Update on Treating Cutaneous T-Cell Lymphoma
- April 1, 1999
- Daniel N. Sauder, MD, FRCPC, University of Toronto Sunnybrook & Women's College Health Sciences Centre
- Dermatology
Cutaneous T-cell lymphoma (CTCL) is a term used to describe a group of clinical diseases that represent neoplastic proliferations of T lymphocytes that preferentially home . . . -
Immunoglobulin Gene Rearrangements in Primary Cutaneous B-Cell Lymphoma
- December 1, 1997
- J Bolognia
- Dermatology
Cutaneous B-cell lymphoma commonly presents as erythematous nodules and plaques. These lesions may be a reflection of systemic disease, or they may represent the sole . . .- Reviewing:
- Gellrich S et al., J Invest Dermatol 1997; 109:
541 545 .
-
Epstein-Barr Virus Associated with Some Subtypes of Cutaneous T-Cell Lymphoma
- January 1, 1994
- BR Smoller
- Dermatology
Cutaneous T-cell lymphomas (CTCL) are now recognized as a group of five diseases: mycosis fungoides, large-cell anaplastic lymphoma, angiocentric T-cell lymphoma, adult T- cell leukemia/lymphoma, . . .- Reviewing:
- Su I-H et al., J Am Acad Dermatol 1993; 29:
685 692 .
-
Cutaneous T Cell Lymphoma in Skin Folds with a Follicular Helper T-Cell Phenotype
- October 12, 2012
- Angelica Selim, MD
- Dermatology
Eosinophils and B-cell lymphocytes in skin-fold tumors can signal a proliferation of follicular helper T cells.- Reviewing:
- Gammon B and Guitart J., Arch Dermatol 2012 Sep 1; 148:1040.
-
Does PUVA Cure Mycosis Fungoides?
- June 14, 2005
- James Ferguson, MD, FRCP
- Dermatology
Epidermotropic lymphocytes characterize mycosis fungoides (MF). In a limited number of cases, early patch-stage disease progresses to a biologically aggressive tumor form with a poor . . .- Reviewing:
- Querfeld C et al., Arch Dermatol 2005 Mar; 141:305-11.
-
CD30+ Lymphoproliferative Disease: The Mysterious Case of the Leg
- August 28, 2009
- Angelica Maria Selim, MD
- Dermatology
The prognosis is different for older patients with extensive leg disease.- Reviewing:
- Woo DK et al., Arch Dermatol 2009 Jun; 145:667.
-
ALK for Diagnosing ALCL: A Case with a Cautionary Note
- January 16, 2009
- Angelica Selim, MD
- Dermatology
A subset of cutaneous anaplastic large cell lymphomas is positive for anaplastic lymphoma kinase, which complicates diagnosis.- Reviewing:
- Kadin ME et al., Am J Surg Pathol 2008 Sep; 32:1421.
Sort by:
Items 1 to 20 of 57 results - Relevance
- Date
